The Psychiatry, Mental Health and Addictions Research Group at the Vall d'Hebron Research Institute is a multidisciplinary team that over the past 14 years has focused its scientific activity on the research (both nationally and internationally) of clinical, therapeutic and etiopathogenic aspects of: Neurodevelopmental Disorders (especially Attention-Deficit / Hyperactivity Disorder, Autism and Fetal Alcohol Syndrome); Personality Disorders (especially Borderline Personality Disorder); Addictive behaviours (especially Dual Pathology and Smoking); Transcultural Psychiatry; Interconsultation and Liaison Psychiatry; Resistant Major Depressive Disorder; Perinatal psychiatry; and Child sexual abuse and maltreatment.
At international level, it participates and/or coordinates several European projects of great repercussion in the area of mental health. And at national level, it is part of the CIBERSAM (Centre for Biomedical Research in Mental Health Network).

Group Leader
José Antonio Ramos Quiroga

Principal Investigator (PI)
Marta Ribasés Haro, Anna Beneria González, Eugeni Bruguera Cortada, Natàlia Calvo Piñero, Francisco Collazos Sanchez, Marc Ferrer Vinardell, Sara Guila Fidel Kinori, Núria Gómez Barros, Lara Grau Lopez, Carlos Jacas Escarcellé, Pilar Lusilla Palacios, José Antonio Navarro Sanchís, Gemma Parramon Puig, Marta Quesada Franco, Vanesa Richarte Fernández, Amanda Rodríguez Urrutia, María Soler Artigas, Laura Gisbert Gustemps

Researchers
Silvia Alemany Sierra, Dimitra Tatiana Anastasiadou, Mª Sonsoles Cepeda Diez, Mª Dolores Braquehais Conesa, Raquel Vidal Estrada, Silvia Amoretti Guadall, Jorge Lugo Marin, Gemma Nieva Rifa, Gabriela Perez Fuentes Ruiz, Elena Ros, Constanza Daigré Blanco, Montserrat Corrales De la Cruz

PhD Students
Gara Arteaga Henriquez, Mireia Forner Puntonet, Zaira Nieto Fernández, Christina Regales Peco, Miguel Angel Sandonis Vicente, Oscar Soto Angona, Laura Vilar Ribo, Pedro Serrano Pérez, Felipe Palma, Gemma Español

Lab Technicians
Lorena Arribas Garcia, Natàlia Llonga

Nursing and Technical Staff
Montserrat Fabregat Garcia, Pol Ibañez Jimenez, Estela García Egea, Judit Palacio Sanchez, Carolina Ramos Sayalero, Alexandre Rue Jimenez, Imanol Setien Ramos, Raquel Ibarz López, Eudald Castell Panisello, Sheila Garcia Prado, Sara García González

63

PUBLICATIONS

346

IMPACT FACTOR

5.49

AVERAGE IMPACT FACTOR

SELECTED ARTICLES

Richarte V, Sánchez-Mora C, Corrales M, Fadeuilhe C, Vilar-Ribó L, Arribas L, Garcia E, Rosales-Ortiz SK, Arias-Vasquez A, Soler-Artigas M, Ribasés M, Ramos- Quiroga JA.
Gut microbiota signature in treatment-naïve attention- deficit/hyperactivity disorder.
Transl Psychiatry. 2021 Jul 8;11(1):382.
DOI: 10.1038/s41398-021-01504-6
IF: 6.22

Mullins N., Forstner A.J., O'Connell K.S., Coombes B., Coleman J.R.I., Qiao Z., Als T.D., Bigdeli T.B., Borte S., Bryois J., Charney A.W., Drange O.K., Gandal M.J., Hagenaars S.P., Ikeda M., Kamitaki N., Kim M., Krebs K., Panagiotaropoulou G., Schilder B.M., Sloofman L.G., Steinberg S., Trubetskoy V., Winsvold B.S., Won H.-H., Abramova L., Adorjan K., Agerbo E., Al Eissa M., Albani D., Alliey-Rodriguez N., Anjorin A., Antilla V., Antoniou A., Awasthi S., Baek J.H., Baekvad-Hansen M., Bass N., Bauer M., Beins E.C., Bergen S.E., Birner A., Bocker Pedersen C., Boen E., Boks M.P., Bosch R., Brum M., Brumpton B.M., Brunkhorst-Kanaan N., Budde M., Bybjerg-Grauholm J., Byerley W., Cairns M., Casas M., Cervantes P., Clarke T.-K., Cruceanu C., Cuellar-Barboza A., Cunningham J., Curtis D., Czerski P.M., Dale A.M., Dalkner N., David F.S., Degenhardt F., Djurovic S., Dobbyn A.L., Douzenis A., Elvsashagen T., Escott-Price V., Ferrier I.N., Fiorentino A., Foroud T.M., Forty L., Frank J., Frei O., Freimer N.B., Frisen L., Gade K., Garnham J., Gelernter J., Giortz Pedersen M., Gizer I.R., Gordon S.D., Gordon-Smith K., Greenwood T.A., Grove J., Guzman-Parra J., Ha K., Haraldsson M., Hautzinger M., Heilbronner U., Hellgren D., Herms S., Hoffmann P., Holmans P.A., Huckins L., Jamain S., Johnson J.S., Kalman J.L., Kamatani Y., Kennedy J.L., Kittel-Schneider S., Knowles J.A., Kogevinas M., Koromina M., Kranz T.M., Kranzler H.R., Kubo M., Kupka R., Kushner S.A., Lavebratt C., Lawrence J., Leber M., Lee H.-J., Lee P.H., Levy S.E., Lewis C., Liao C., Lucae S., Lundberg M., MacIntyre D.J., Magnusson S.H., Maier W., Maihofer A., Malaspina D., Maratou E., Martinsson L., Mattheisen M., McCarroll S.A., McGregor N.W., McGuffin P., McKay J.D., Medeiros H., Medland S.E., Millischer V., Montgomery G.W., Moran J.L., Morris D.W., Muhleisen T.W., O'Brien N., O'Donovan C., Olde Loohuis L.M., Oruc L., Papiol S., Pardinas A.F., Perry A., Pfennig A., Porichi E., Potash J.B., Quested D., Raj T., Rapaport M.H., DePaulo J.R., Regeer E.J., Rice J.P., Rivas F., Rivera M., Roth J., Roussos P., Ruderfer D.M., Sanchez-Mora C., Schulte E.C., Senner F., Sharp S., Shilling P.D., Sigurdsson E., Sirignano L., Slaney C., Smeland O.B., Smith D.J., Sobell J.L., Soholm Hansen C., Soler Artigas M., Spijker A.T., Stein D.J., Strauss J.S., Swiatkowska B., Terao C., Thorgeirsson T.E., Toma C., Tooney P., Tsermpini E.-E., Vawter M.P., Vedder H., Walters J.T.R., Witt S.H., Xi S., Xu W., Yang J.M.K., Young A.H., Young H., Zandi P.P., Zhou H., Zillich L., Adolfsson R., Agartz I., Alda M., Alfredsson L., Babadjanova G., Backlund L., Baune B.T., Bellivier F., Bengesser S., Berrettini W.H., Blackwood D.H.R., Boehnke M., Borglum A.D., Breen G., Carr V.J., Catts S., Corvin A., Craddock N., Dannlowski U., Dikeos D., Esko T., Etain B., Ferentinos P., Frye M., Fullerton J.M., Gawlik M., Gershon E.S., Goes F.S., Green M.J., Grigoroiu-Serbanescu M., Hauser J., Henskens F., Hillert J., Hong K.S., Hougaard D.M., Hultman C.M., Hveem K., Iwata N., Jablensky A.V., Jones I., Jones L.A., Kahn R.S., Kelsoe J.R., Kirov G., Landen M., Leboyer M., Lewis C.M., Li Q.S., Lissowska J., Lochner C., Loughland C., Martin N.G., Mathews C.A., Mayoral F., McElroy S.L., McIntosh A.M., McMahon F.J., Melle I., Michie P., Milani L., Mitchell P.B., Morken G., Mors O., Mortensen P.B., Mowry B., Muller-Myhsok B., Myers R.M., Neale B.M., Nievergelt C.M., Nordentoft M., Nothen M.M., O'Donovan M.C., Oedegaard K.J., Olsson T., Owen M.J., Paciga S.A., Pantelis C., Pato C., Pato M.T., Patrinos G.P., Perlis R.H., Posthuma D., Ramos-Quiroga J.A., Reif A., Reininghaus E.Z., Ribases M., Rietschel M., Ripke S., Rouleau G.A., Saito T., Schall U., Schalling M., Schofield P.R., Schulze T.G., Scott L.J., Scott R.J., Serretti A., Shannon Weickert C., Smoller J.W., Stefansson H., Stefansson K., Stordal E., Streit F., Sullivan P.F., Turecki G., Vaaler A.E., Vieta E., Vincent J.B., Waldman I.D., Weickert T.W., Werge T., Wray N.R., Zwart J.-A., Biernacka J.M., Nurnberger J.I., Cichon S., Edenberg H.J., Stahl E.A., McQuillin A., Di Florio A., Ophoff R.A., Andreassen O.A.
Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology
Nat Genet . 2021 Jun;53(6):817-829. doi: 10.1038/s41588-021-00857-4.
DOI: 10.1038/s41588-021-00857-4
IF: 38.33

Sforzini L., Worrell C., Kose M., Anderson I.M., Aouizerate B., Arolt V., Bauer M., Baune B.T., Blier P., Cleare A.J., Cowen P.J., Dinan T.G., Fagiolini A., Ferrier I.N., Hegerl U., Krystal A.D., Leboyer M., McAllister-Williams R.H., McIntyre R.S., Meyer-Lindenberg A., Miller A.H., Nemeroff C.B., Normann C., Nutt D., Pallanti S., Pani L., Penninx B.W.J.H., Schatzberg A.F., Shelton R.C., Yatham L.N., Young A.H., Zahn R., Aislaitner G., Butlen-Ducuing F., Fletcher C., Haberkamp M., Laughren T., Mantyla F.-L., Schruers K., Thomson A., Arteaga-Henriquez G., Benedetti F., Cash-Gibson L., Chae W.R., De Smedt H., Gold S.M., Hoogendijk W.J.G., Mondragon V.J., Maron E., Martynowicz J., Melloni E., Otte C., Perez-Fuentes G., Poletti S., Schmidt M.E., van de Ketterij E., Woo K., Flossbach Y., Ramos-Quiroga J.A., Savitz A.J., Pariante C.M.
A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials
Mol Psychiatry . 2021 Dec 15.
DOI: 10.1038/s41380-021-01381-x
IF: 15.99

Demontis D., Walters R.K., Rajagopal V.M., Waldman I.D., Grove J., Als T.D., Dalsgaard S., Ribasas M., Bybjerg-Grauholm J., Baekvad-Hansen M., Werge T., Nordentoft M., Mors O., Mortensen P.B., Andreassen O.A., Arranz M.J., Banaschewski T., Bau C., Bellgrove M., Biederman J., Brikell I., Buitelaar J.K., Burton C.L., Casas M., Crosbie J., Doyle A.E., Ebstein R.P., Elia J., Elizabeth C.C., Grevet E., Grizenko N., Havdahl A., Hawi Z., Hebebrand J., Hervas A., Hohmann S., Haavik J., Joober R., Kent L., Kuntsi J., Langley K., Larsson H., Lesch K.-P., Leung P.W.L., Liao C., Loo S.K., Martin J., Martin N.G., Medland S.E., Miranda A., Mota N.R., Oades R.D., Ramos-Quiroga J.A., Reif A., Rietschel M., Roeyers H., Rohde L.A., Rothenberger A., Rovira P., Sanchez-Mora C., Schachar R.J., Sengupta S., Artigas M.S., Steinhausen H.-C., Thapar A., Witt S.H., Yang L., Zayats T., Zhang-James Y., Cormand B., Hougaard D.M., Neale B.M., Franke B., Faraone S.V., Borglum A.D.
Risk variants and polygenic architecture of disruptive behavior disorders in the context of attention-deficit/hyperactivity disorder
Nature Communications. 2021;12(1).
DOI: 10.1038/s41467-020-20443-2
IF: 14.91

Luderer M., Ramos Quiroga J.A., Faraone S.V., Zhang James Y., Reif A.
Alcohol use disorders and ADHD

DOI: 10.1016/j.neubiorev.2021.07.010
IF: 8.98

TIMESPAN: Management of chronic cardiometabolic disease and treatment discontinuity in adult ADHD patients
Principal Investigator: José Antonio Ramos-Quiroga
Agency: International European Comission (Horizon 2020)
Funding: 499,986€
Period: 2021-2025

DISCOvERIE: Development, dIagnosis and prevention of gender-related Somatic and mental COmorbiditiEs in iRrItable bowel syndrome in Europe
Principal Investigator: José Antonio Ramos-Quiroga
Agency: International European Comission (Horizon 2020-IMI2)
Funding: 203,663€
Period: 2020-2024

Eat2beNICE: Effects of Nutrition and Lifestyle on Impulsive, Compulsive, and Externalizing behaviors
Principal Investigator: José Antonio Ramos-Quiroga
Agency: International European Comission (Horizon 2020-IMI2)
Funding: 479,789€
Period: 2017-2023

PEARL: EU Patient- cEntric clinicAl tRial pLatform
Principal Investigator: José Antonio Ramos-Quiroga
Agency: International European Comission (Horizon 2020-IMI2)
Funding: 1,987,375€
Period: 2019-2023

CoCA: Comorbid Conditions of Attention Deficit/Hyperactivity disorder
Principal Investigator: José Antonio Ramos-Quiroga
Agency: European Commission (Horizon 2020)
Funding: 479,789.91€
Period: 2017-2022

METHODS OF TREATING BORDERLINE PERSONALITY DISORDER
Priority Number: PCT/EP2020/057803
Priority Date: 20/03/2019
Applicants: Oryzon Genomics, S.A

METHODS OF TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER USING KDM1A INHIBITORS SUCH AS THE COMPOUND VAFIDEMSTAT
Priority Number: PCT/EP2020/057800
Priority Date: 20/03/2019
Applicants: Oryzon Genomics, S.A

VAFIDEMSTAT FOR USE IN TREATING AUTISM SPECTRUM DISORDERS
Priority Number: PCT/EP2020/074602
Priority Date: 20/03/2019
Applicants: Oryzon Genomics, S.A